Form 4: Zimmer Biomet Director Reports Phantom Stock Units

Zimmer Biomet Holdings, Inc. Director Devdatt Kurdikar reported the accrual of 180.323 phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.

Summary

• Devdatt Kurdikar, a Director at Zimmer Biomet Holdings, Inc., has reported the accrual of 180.323 phantom stock units.
• These units were granted under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The phantom stock units have a conversion or exercise price of 1-for-1 and are valued at $86.65 per unit.
• The units are set to be settled in shares of Company common stock within sixty days after Mr. Kurdikar ceases to serve as a Director.
• The earliest transaction date associated with this filing is June 30, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine disclosure of director compensation and does not indicate significant new financial performance or strategic shifts.

Positives

• Director compensation plan is active and being utilized.
• Phantom stock units provide a mechanism for aligning director interests with shareholder value over time.

Risks

• The value of the phantom stock units is subject to the future performance of Zimmer Biomet Holdings, Inc. common stock.
• Cessation of service as a Director triggers settlement, which could be influenced by various factors.

Future Outlook

The phantom stock units will be settled in shares of Company common stock within sixty days after the reporting person's cessation of service as a Director.

Industry Context

StockSavvy.ai notes that the use of phantom stock units is a common practice in the medical device industry for director compensation, aiming to align long-term incentives with company performance.

Stakeholder Impact

• Shareholders: The issuance of shares upon settlement of phantom stock units will result in minor dilution.

Next Steps

• Settlement of phantom stock units in shares of Company common stock within sixty days after cessation of director service.

Key Dates

Keywords

Zimmer Biomet Holdings, Devdatt Kurdikar, Form 4, Phantom Stock Units, Deferred Compensation Plan, Director Compensation, SEC Filing, Insider Trading